Shareholders' Equity of the Company
|9 Months Ended|
Sep. 30, 2019
|Schedule of Shareholders' Equity of the Company [Line Items]|
|Share Repurchase Program||Shareholders’ Equity of the Company
Share Repurchase Program
In February 2019, the Company’s Board of Directors authorized the repurchase of an additional $44.3 million of our outstanding common shares for an aggregate authorization of $169.3 million until May 2021. Repurchases may be made from time to time through open market, privately-negotiated, structured or derivative transactions (including accelerated share repurchase transactions), or other methods of acquiring shares. The Company intends to structure open market purchases to occur within pricing and volume requirements of Rule 10b-18. The Company may, from time to time, enter into Rule 10b5-1 plans to facilitate the repurchase of its shares under this authorization.
Shares repurchased are as follows:
The remaining amount authorized to be repurchased under the program as of September 30, 2019 was approximately $80.0 million.
Schedule of Shareholders' Equity of the Company [Line Items]
No definition available.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef